Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Viral therapeutics

where we are and where we are going

Chemaly, Roy F.a; Clark, Tristan W.b,c,d

Current Opinion in Infectious Diseases: December 2018 - Volume 31 - Issue 6 - p 512–513
doi: 10.1097/QCO.0000000000000507
ANTIMICROBIAL AGENTS: VIRAL: Edited by Tristan W. Clark and Roy F. Chemaly

aDepartment of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

bAcademic Unit of Clinical and Experimental Sciences, University of Southampton

cDepartment of Infection

dNIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK

Correspondence to Tristan W. Clark, MD, LF101, South Academic Block, Southampton General Hospital, Southampton, SO16 6YD, UK. Tel: +44(0)2381208410; e-mail: T.W.Clark@soton.ac.uk

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.